Goodwill and Intangible Assets (Tables)

3 Months Ended

Sep. 30, 2015

Goodwill and Intangible Assets

Schedule of changes in the carrying amount of goodwill

(In thousands)	Generic Pharmaceuticals
Balance at June 30, 2015	$	141
Goodwill acquired	—
Impairments	—
Balance at September 30, 2015	$	141

Summary of intangible assets, net

		Gross Carrying Amount				Accumulated Amortization						Intangible Assets, Net
(In thousands)	Weighted Avg. Life (Yrs.)	September 30, 2015		June 30, 2015		September 30, 2015			June 30, 2015			September 30, 2015		June 30, 2015
Definite-lived:
Cody Labs import license	15	582		582		(279		)	(269		)	303		313
Silarx product rights	15	10,000		10,000		(222		)	(56		)	9,778		9,944
Other product rights	14	653		653		(280		)	(269		)	373		384
Total definite-lived		11,235		11,235		(781		)	(594		)	10,454		10,641
Indefinite-lived:
Other product rights	—	449		449		—			—			449		449
Silarx in-process research and development	—	18,000		18,000		—			—			18,000		18,000
Total indefinite-lived		18,449		18,449		—			—			18,449		18,449
Total intangible assets, net		$	29,684	$	29,684	$	(781	)	$	(594	)	$	28,903	$	29,090

Summary of future annual amortization expense

(In thousands) Fiscal Year Ending June 30,	Annual Amortization Expense
2016	$	561
2017	748
2018	748
2019	746
2020	739
Thereafter	6,912
	$	10,454